Log in to search using one of your social media accounts:

 

Rigel Welcomes Brian Kotzin, M.D. to Board of Directors
SOUTH SAN FRANCISCO, Calif., Aug. 25, 2017 -- (Healthcare Sales & Marketing Network) -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Brian L. Kotzin, M.D. has been appointed to Rigel's board of directors. A well-respected former profess... Biopharmaceuticals, Personnel Rigel Pharmaceuticals, Tavalisse, fostamatinib, immune thrombocytopenia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 25, 2017 Category: Pharmaceuticals Source Type: news

FDA Accepts Rigel's New Drug Application for TAVALISSE(TM) (fostamatinib disodium) for the Treatment of Chronic ITP
SOUTH SAN FRANCISCO, Calif., June 19, 2017 -- (Healthcare Sales & Marketing Network) -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the U.S. Food and Drug Administration (FDA) has filed its New Drug Application (NDA) for the use of TAVALISS... Biopharmaceuticals, FDA Rigel Pharmaceuticals, TAVALISSE, fostamatinib, thrombocytopenia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 19, 2017 Category: Pharmaceuticals Source Type: news

A Newborn With Cutaneous Lesions and Hematochezia A Newborn With Cutaneous Lesions and Hematochezia
Can you identify the underlying cause of this newborn's dermal lesion, thrombocytopenia, and rectal bleeding?Medscape Pediatrics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 12, 2017 Category: Consumer Health News Tags: Pediatrics Clinical Case Source Type: news

What Causes Anemia?
Discussion One of the most common problems in pediatrics is anemia. It is defined as “a lower than normal value for the related measurements of hemoglobin, hematocrit, and number of red blood cells”, usually 2 standard deviations below the normal for age. Normal hematological values change with age. For a discussion of which values are used click here. The most common type of anemia in childhood is iron deficiency which is commonly caused by inadequate stores (e.g. premature infant), inadequate intake (e.g. poor nutrition) or blood loss (e.g. menses). Anemia screening is recommended at age 9-12 months, and for...
Source: PediatricEducation.org - May 15, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Rigel Announces Tavalisse(TM) as Proprietary Name for Fostamatinib in the United States
SOUTH SAN FRANCISCO, Calif., April 27, 2017 -- (Healthcare Sales & Marketing Network) -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that the U.S. Food and Drug Administration (FDA) has conditionally accepted the proprietary name Tavalisse™... Biopharmaceuticals, Oncology Rigel Pharmaceuticals, Tavalisse, fostamatinib, immune thrombocytopenia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 27, 2017 Category: Pharmaceuticals Source Type: news

Rigel Pharmaceuticals submits NDA to FDA for Fostamatinib to treat chronic ITP
Rigel Pharmaceuticals has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for an oral investigational drug candidate, Fostamatinib, for the treatment of chronic and persistent immune thrombocytopenia (ITP). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - April 18, 2017 Category: Pharmaceuticals Source Type: news

Rigel Submits New Drug Application to FDA for Fostamatinib in Chronic ITP
SOUTH SAN FRANCISCO, Calif., April 17, 2017 -- (Healthcare Sales & Marketing Network) -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for fosta... Biopharmaceuticals Rigel Pharmaceuticals, fostamatinib, immune thrombocytopenia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 17, 2017 Category: Pharmaceuticals Source Type: news

Presentation of Severe Fever With Thrombocytopenia Syndrome Presentation of Severe Fever With Thrombocytopenia Syndrome
This case details an unusual presentation of encephalopathy in a patient with severe fever with thrombocytopenia syndrome, an emerging infectious disease that has recently been identified in Asia.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 14, 2017 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

Eltrombopag Improved Platelet Counts in Thrombocytopenic MDS Patients
The use of the thrombopoietin receptor agonist eltrombopag was clinically effective at raising platelet counts in patients with lower-risk myelodysplastic syndromes with severe thrombocytopenia. (Source: CancerNetwork)
Source: CancerNetwork - February 10, 2017 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Hematologic Malignancies Myelodysplastic Syndromes News Source Type: news

Ocular Complications of Congenital Infections
This article summarizes the ocular complications of the 5 infections typically represented by the acronym TORCHES (toxoplasmosis, rubella, cytomegalovirus, herpes simplex, and syphilis), as well as others, including newer pathogens such as the human immunodeficiency, West Nile, and Zika viruses. (Source: NeoReviews recent issues)
Source: NeoReviews recent issues - January 31, 2017 Category: Pediatrics Authors: Khazaeni, L. M. Tags: Pediatric Drug Labeling Update Articles Source Type: news

[Report] IgG antibodies to dengue enhanced for Fc γRIIIA binding determine disease severity
Dengue virus (DENV) infection in the presence of reactive, non-neutralizing immunoglobulin G (IgG) (RNNIg) is the greatest risk factor for dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS). Progression to DHF/DSS is attributed to antibody-dependent enhancement (ADE); however, because only a fraction of infections occurring in the presence of RNNIg advance to DHF/DSS, the presence of RNNIg alone cannot account for disease severity. We discovered that DHF/DSS patients respond to infection by producing IgGs with enhanced affinity for the activating Fc receptor FcγRIIIA due to afucosylated Fc glycans and IgG1...
Source: ScienceNOW - January 26, 2017 Category: Science Authors: Taia T. Wang Source Type: news

Severe Thrombocytopenia in a Child With Typhoid Fever Severe Thrombocytopenia in a Child With Typhoid Fever
How should thrombocytopenia in typhoid fever be managed? The successful outcome of this occurrence in a young traveler provides some guidance.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 6, 2017 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news

Amgen Announces Presentation Of New Data In Acute Lymphoblastic Leukemia, Multiple Myeloma And Immune Thrombocytopenia At ASH 2016
Sub-Analysis From Phase 3 TOWER Study Compares Health-Related Quality of Life of BLINCYTO® (Blinatumomab) to Standard of Care Chemotherapy Analysis of Phase 3 Data Evaluates Cost-Effectiveness of KYPROLIS® (Carfilzomib) in Combination With Dexamethasone for Relapsed Multiple Myeloma Patients Long-Term Data Provide Insights on Safety and Efficacy of Nplate® (Romiplostim) in Children With Immune Thrombocytopenia THOUSAND OAKS, Calif., Nov. 30, 2016 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new data will be presented at the 58th Annual Meeting and Exposition of the American Society of Hemat...
Source: Amgen News Release - November 30, 2016 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Assessing Fever in Returning Travelers: Part II
  Zika continues to be the virus of the day for returning travelers, but there are several other diseases that we need to consider in these patients when they present to us in the emergency department. Chikungunya is epidemic in many of the same countries as Zika and can be even more devastating. And Avian and MERS-CoV is still present in many countries. Unlike patients infected with Zika virus, these patients do require isolation to protect our health care staff from infection. Chikungunya Chikungunya, which means “to walk bent over,” was likely endemic but unrecognized in the United States before the mos...
Source: EPMonthly.com - November 25, 2016 Category: Emergency Medicine Authors: Matt McGahen Tags: Uncategorized Source Type: news

Middle-Aged Man With Acute Thrombocytopenia Subsequent to Fluorouracil and Oxaliplatin Chemotherapy for Colorectal Cancer
A 44-year-old patient with a history of stage IIB colorectal cancer at the hepatic flexure, invading the duodenum and pancreas, was initially diagnosed in September 2005 and received modified Whipple surgery and 8 cycles of adjuvant chemotherapy with capecitabine and oxaliplatin every 3 weeks. (Source: CancerNetwork)
Source: CancerNetwork - November 15, 2016 Category: Cancer & Oncology Authors: Henning Schade, MD Lindsey Davis, MD Peter Kabos, MD Tags: Case Studies Colorectal Cancer Oncology Journal Source Type: news

Mayo Clinic PathWays: What's the diagnosis?
This week's case involves?review of a peripheral smear from a 42-year-old man with lifelong mild thrombocytopenia. View the case and make your diagnosis. Learn more about Mayo Clinic PathWays. (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 19, 2016 Category: Databases & Libraries Source Type: news

Preterm Thrombocytopenia Tied to Delayed Closure of Patent Ductus Arteriosus Preterm Thrombocytopenia Tied to Delayed Closure of Patent Ductus Arteriosus
Thrombocytopenia is an independent risk factor for failure of patent ductus arteriosus (PDA) closure and more hemodynamically significant PDA in preterm infants, according to new findings from India.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - September 30, 2016 Category: Radiology Tags: Pediatrics News Source Type: news

Spleen stiffness correlates with cirrhosis complication
The progression of thrombocytopenia, or blood platelet deficiency, in cirrhotic...Read more on AuntMinnie.comRelated Reading: Can elastography help guide breast cancer treatment? Shear-wave elastography can predict esophageal varices Fans of contrast ultrasound celebrate FDA approval Quantitative ultrasound method stages fatty liver Panel says elastography has value for liver fibrosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 2, 2016 Category: Radiology Source Type: news

Rigel's Bleeding Disorder Drug Clears First of Two Key Trials Rigel's Bleeding Disorder Drug Clears First of Two Key Trials
Rigel Pharmaceuticals Inc said its experimental drug to treat chronic immune thrombocytopenia (ITP) met its main goal in the first of two late-stage trials, sending its shares up 12 pct in premarket trade.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 1, 2016 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Genetics Home Reference: immune thrombocytopenia
https://ghr.nlm.nih.gov/condition/immune-thrombocytopenia (Source: NLM General Announcements)
Source: NLM General Announcements - August 30, 2016 Category: Databases & Libraries Source Type: news

Thrombocytopenia (Low Platelet Count)
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 13, 2016 Category: Journals (General) Source Type: news

Utah Resident Becomes First Zika-Related Death In U.S.
By Julie Steenhuysen CHICAGO (Reuters) - The Centers for Disease Control and Prevention has confirmed that a Utah resident’s death last month is the first Zika-related death in the continental United States, the CDC said in an emailed statement. Health officials in the Salt Lake County health department in Utah reported the death on Friday of an elderly resident who had been infected with the Zika virus while traveling to an area with active transmission of the virus. The exact cause of death is not known, the health department said in a press release. The resident had an undisclosed health condition and had tested p...
Source: Healthy Living - The Huffington Post - July 8, 2016 Category: Consumer Health News Source Type: news

Case 2: Neonate with Cholestasis, Thrombocytopenia, and Hypoglycemia
(Source: NeoReviews recent issues)
Source: NeoReviews recent issues - June 30, 2016 Category: Pediatrics Authors: Velazquez, D. M., Ovchinsky, N., Taragin, B., Bruno, C. J. Tags: Pediatric Drug Labeling Update Index of Suspicion in the Nursery Source Type: news

Legal Briefs: In Utero Cerebral Hemorrhage and Alloimmune Thrombocytopenia: Was It Preventable?
(Source: NeoReviews recent issues)
Source: NeoReviews recent issues - June 30, 2016 Category: Pediatrics Authors: Sims, M. E. Tags: Pediatric Drug Labeling Update Index of Suspicion in the Nursery Source Type: news

Cells Detachment
Easy, Gentle and CompleteI often get asked if trypsin is the best reagent to detach primary and stem cells. The problem with a trypsin is that it could lyse a percentage of the cells.We recommend our DetachinTM. It offers the following benefits:Gentle and rapid detachment.Maximum cell viability.Effective on a wide range of cells.No mammalian or bacterial byproducts.Stable at 4°C for 2 months.No need to wash detached cells.Here's a recent publication referencing the use of Detachin: Yu Hou, Qi Feng, Miao Xu, Guo-sheng Li, Xue-na Liu, Zi Sheng, Hai Zhou, Ji Ma, Yu Wei,1 Yuan-xin Sun,Ying-yi Yu, Ji-hua Qiu, Lin-lin S...
Source: Neuromics - June 28, 2016 Category: Neuroscience Tags: Astrocyte-Glial-Neuron Co-cultures Cell based assays Detachin Neurons stem cell based assays Source Type: news

Thrombocytopenia After Reversal of Anticoagulation for SurgeryThrombocytopenia After Reversal of Anticoagulation for Surgery
What was the cause of the sudden development of severe thrombocytopenia in this patient post-surgical blood transfusions? Laboratory Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 20, 2016 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news

Inherited thrombocytopenia type is a risk factor for hematologic cancers
Copenhagen – Investigators in Italy have found that a recently identified form of inherited thrombocytopenia related to mutations in the gene ETV6 (ETV6-RT) appears to be largely asymptomatic, but... (Source: Pediatric News)
Source: Pediatric News - June 11, 2016 Category: Journals (General) Source Type: news

Inherited thrombocytopenia type is a risk factor for hematologic cancers
Copenhagen – Investigators in Italy have found that a recently identified form of inherited thrombocytopenia related to mutations in the gene ETV6 (ETV6-RT) appears to be largely asymptomatic, but... (Source: Family Practice News)
Source: Family Practice News - June 11, 2016 Category: Primary Care Source Type: news

CDC Reports First U.S. Zika Death In Puerto Rico
Puerto Rico has 683 confirmed cases of the Zika virus, including 65 pregnant women with symptoms of the virus and one death, U.S. health officials said on Friday. Officials who have been tracking cases of the mosquito-borne illness since December, say five patients with suspected cases of the paralyzing nerve disorder Guillain-Barre syndrome have tested positive for the Zika virus, according to a report published by the U.S. Centers for Disease Control and Prevention. The CDC also reported that one patient with a confirmed Zika infection died from severe thrombocytopenia, a disorder marked by abnormally low blood platelets...
Source: Healthy Living - The Huffington Post - April 29, 2016 Category: Consumer Health News Source Type: news

Make the Diagnosis: Smear Savvy
(MedPage Today) -- Case Findings: A 45-year old male patient with no significant past medical history presents with recurrent fevers, fatigue, arthralgias, and general malaise that have persisted for the past two months. He denies any weight loss, nausea, vomiting, abdominal pain, or headaches. He is a Boy Scout leader who spent the summer chaperoning at a Boy Scout camp. A physical examination shows fever, scleral icterus, and mild hepatosplenomegaly. Laboratory studies reveal anemia, elevated lactate dehydrogenase, thrombocytopenia, elevated total bilirubin, low haptoglobin, reticulocytosis, elevated liver enzymes, a...
Source: MedPage Today Public Health - April 21, 2016 Category: American Health Source Type: news

Nplate® (Romiplostim) Study In The Lancet Shows Significant Increase In Durable Platelet Response Among Children With Immune Thrombocytopenia
Nplate Reduced Rates of Bleeding by More Than 30 Percent in Children Affected by Blood Disorder THOUSAND OAKS, Calif., April 19, 2016 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that The Lancet published results from a Phase 3 randomized, double-blind, placebo-controlled study of Nplate® (romiplostim) in children with symptomatic immune thrombocytopenia (ITP). The study showed that 52 percent of Nplate patients achieved a durable platelet response, compared with 10 percent of placebo-treated patients (p=0.002, odds ratio 9.1, 95 percent CI: 1.9, 43.2). "Children with ITP are at risk for seriou...
Source: Amgen News Release - April 19, 2016 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

What Are Common Causes of Congenital Aplastic Anemia?
Discussion Aplastic anemia are disorders where there is inadequate production of erythrocytes, granulocytes and platelets caused by decreased bone marrow production leading to a peripheral blood pancytopenia. Most often it is acquired because of exposures to infections (especially viruses such as Epstein-Barr virus, rubella, herpes, etc.), drugs (e.g. chloramphenicol, chemotherapeutic agents, etc.), toxins or radiation. Learning Point The most common congenital bone marrow failure syndromes causing pancytopenia are (in this order) Fanconi anemia, Diamond-Blackfan anemia, and Shwachman-Diamond anemia. Most have a variety of...
Source: PediatricEducation.org - April 17, 2016 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Thrombocytopenia: Symptoms, Treatment, and...
Chemotherapy for breast cancer affects all the rapidly dividing cells in your body, including bone marrow cells, which make platelets, and red and white blood cells. Thrombocytopenia is defined as having a low platelet count. Learn about symptoms, risks, and treatment for chemo-induced thrombocytopenia. (Source: About.com Breast Cancer)
Source: About.com Breast Cancer - April 14, 2016 Category: Cancer & Oncology Authors: breastcancer.guide at about.com Tags: health Source Type: news

Four cases of successful treatment after 'Podostroma cornu-damae' intoxication - Park JS, Min JH, Kim H, Lee SW, Kang JH, An JY.
Four individuals mistook 'Podostroma cornu-damae' for 'Cordyceps sobolifera' and reported diarrhoea and vomiting after consuming the toxic mushroom. All symptoms resolved within four days. However, leukocytopenia, thrombocytopenia, depilation, and desquama... (Source: SafetyLit)
Source: SafetyLit - April 14, 2016 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news

FDA Approves Venclexta (Venetoclax) for a Type of Chronic Lymphocytic Leukemia
By Stacy SimonThe US Food and Drug Administration (FDA) has approved a new targeted therapy for a certain type of chronic lymphocytic leukemia (CLL). The drug Venclexta (venetoclax) treats people with CLL whose leukemia cells have a chromosome abnormality called 17p deletion and who have had at least one treatment already. It targets BCL-2, a protein in CLL cells that helps them live longer than they should.The FDA based its approval on a study of 106 people with CLL who have a 17p deletion and who had received at least one previous therapy. All the participants were given Venclexta. Results showed that 80% of them either ...
Source: American Cancer Society :: News and Features - April 13, 2016 Category: Cancer & Oncology Tags: Leukemia - Chronic Lymphocytic (CLL) Source Type: news

Thrombocytopenia signals multiorgan system failure in acute liver failure
In patients with acute liver failure (ALF), decreasing platelet counts after hospital admission signaled systemic inflammation and a greater likelihood of systemic complications, such as high-grade... (Source: Family Practice News)
Source: Family Practice News - February 25, 2016 Category: Primary Care Source Type: news

Anticoagulation in Cancer Patients With ThrombocytopeniaAnticoagulation in Cancer Patients With Thrombocytopenia
New data support the safety and efficacy of following guidelines for therapeutic LMWH dose modification in cancer patients receiving anticoagulation. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 15, 2015 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

BRAVO 3: Bivalirudin No Better Than Heparin in TAVRBRAVO 3: Bivalirudin No Better Than Heparin in TAVR
In BRAVO 3, the use of bivalirudin yielded no benefit over unfractionated heparin, which experts say should limit its use to a small segment of patients, such as those with heparin-induced thrombocytopenia. Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 15, 2015 Category: Cardiology Tags: Cardiology News Source Type: news

Medical News Today: Treatment for rare bleeding disorder effective and well-tolerated, studies show
Two international studies show eltrombopag is an effective and well-tolerated treatment for children with persistent or chronic immune thrombocytopenia, a rare bleeding disorder. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 9, 2015 Category: Consumer Health News Tags: Blood / Hematology Source Type: news

Falling Platelets a Tip-Off for Lupus Lungs (CME/CE)
(MedPage Today) -- A history of thrombocytopenia is strongest risk factor for diffuse alveolar hemorrhage (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - September 25, 2015 Category: Respiratory Medicine Source Type: news

Platelet participation in the pathogenesis of dermonecrosis induced by Loxosceles gaucho venom - Tavares FL, Peichoto ME, Marcelino JR, Barbaro KC, Cirillo MC, Santoro ML, Sano-Martins IS.
Loxosceles gaucho spider venom induces in vitro platelet activation and marked thrombocytopenia in rabbits. Herein, we investigated the involvement of platelets in the development of the dermonecrosis induced by L. gaucho venom, using thrombocytopenic rabb... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - August 18, 2015 Category: Global & Universal Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Novel triple therapy in ITP provides enduring responses
For patients with chronic primary immune thrombocytopenia, a three-drug regimen was associated with a high response rate and relapse-free survival, according to the results of a single-arm, phase IIb trial published online in Blood. Twenty patients with primary immune thrombocytopenia (ITP)... (Source: Skin and Allergy News)
Source: Skin and Allergy News - August 11, 2015 Category: Dermatology Source Type: news

Eltrombopag yields 40% response rate in pediatric immune thrombocytopenia
Treatment with the thrombopoietin receptor agonist eltrombopag led to a sustained platelet response in 40% of children and adolescents with chronic immune thrombocytopenia, compared with only 3% of the placebo group, according to a randomized multicenter trial published online in The... (Source: Skin and Allergy News)
Source: Skin and Allergy News - August 4, 2015 Category: Dermatology Source Type: news

Your NEJM Group Today: Heparin-Induced Thrombocytopenia Clinical Pearls, Unruptured Aneurysm Guideline, North Carolina Primary Care Opportunity (FREE)
By the Editors NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:Now@NEJM: Clinical Pearls: Who is … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - July 23, 2015 Category: Primary Care Source Type: news

Your NEJM Group Today: Heparin-Induced Thrombocytopenia, Pneumonia Causes, NY Hospitalist Opportunities (FREE)
By the Editors NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:NEJM Clinical Practice Center: Clinical Practice: … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - July 21, 2015 Category: Primary Care Source Type: news

Study in mice may identify new ways to treat immune thrombocytopenia
(Source: St. Michael's Hospital News and Media)
Source: St. Michael's Hospital News and Media - July 18, 2015 Category: Hospital Management Tags: Hospital News Source Type: news

Study in mice may identify new ways to treat immune thrombocytopenia
A study in mice may identify new ways to treat immune thrombocytopenia. Immune thrombocytopenia, or ITP, is an autoimmune disease whereby the immune system sends antibodies to attack and destroy the body's platelets--blood cells responsible for controlling bleeding. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 17, 2015 Category: Science Source Type: news

Study in mice may identify new ways to treat immune thrombocytopenia
(St. Michael's Hospital) A study in mice may identify new ways to treat immune thrombocytopenia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 17, 2015 Category: Global & Universal Source Type: news